US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OSR Holdings

0.4749

-0.0071-1.47%

Volume:289.26K

Turnover:139.62K

Market Cap:12.19M

PE:-1.14

High:0.5000

Open:0.4850

Low:0.4700

Close:0.4820

52wk High:10.00

52wk Low:0.4530

Shares:25.67M

Float Shares:2.34M

Volume Ratio:1.26

T/O Rate:12.35%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4165

EPS(LYR):-0.5379

ROE:-8.95%

ROA:-1.80%

PB:0.15

PE(LYR):-0.88

Loading ...

Overview Company News Filings

OSR Holdings CEO says fundamentals of business ‘remain strong’

OSR Holdings Advances Toward VXM01 Licensing Deal With BCM Europe AG

OSR Holdings Closes Woori IO Acquisition

OSR Holdings Subsidiary Acquires Woori IO to Expand Medtech

Osr Holdings Inc: Evaluating Whether a Combined Platform Could Support a Standalone IPO in Korea

THOMSON REUTERS

Osr Holdings Inc: Reviews Strategic Combination of Medical Device Subsidiaries

THOMSON REUTERS

Woori IO Accelerates Launch of Noninvasive Glucose Wearables Under OSR Holdings

Vaximm Appoints Sébastien Wieckowski as Chief Scientific Officer

OSR Holdings Subsidiary Signs Binding VXM01 Licensing Term Sheet

BRIEF-Osr Holdings Inc - Vaximm AG Enters Binding Term Sheet With Bcm Europe AG - SEC Filing

Osr Holdings Inc - Bcme to Pay Vaximm $30 Mln Upfront and $815 Mln in Milestones - SEC Filing

THOMSON REUTERS

Vaximm Secures $30M Upfront Licensing Deal for VXM01 Through BCM Europe-Managed Fund

Vaximm, an Osr Company, Receives Binding Term Sheet From Bcm Europe for Global Exclusive License of Vxm01 With $30M Upfront and up to $815M in Milestones

THOMSON REUTERS

OSR Holdings Receives Binding Term Sheet for Global VXM01 License Worth Up to $845 Million

BRIEF-OSR Holdings Says Woori IO Shareholders Approve Share Exchange To Become Unit Of Co

Woori IO Shareholders Approve Share Exchange with OSR Holdings

Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of Osr Holdings

THOMSON REUTERS

Emerging Growth Research Reaffirms Buy on OSR Holdings With $10 Price Target

Osr Holdings Inc - Vaximm Ag Shortens Exclusivity Period With Bcm Europe to Three Months

THOMSON REUTERS

Vaximm AG Shortens Exclusivity Period With BCM Europe for Cancer Immunotherapy Deal

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OSRH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OSRH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OSRH\",,,,,undefined,":{"symbol":"OSRH","market":"US","secType":"STK","nameCN":"OSR Holdings","latestPrice":0.4749,"timestamp":1770916233324,"preClose":0.482,"halted":0,"volume":289257,"delay":0,"changeRate":-0.014730290456431526,"floatShares":2342900,"shares":25672788,"eps":-0.416535,"marketStatus":"Trading","change":-0.0071,"latestTime":"02-12 12:13:09 EST","open":0.485,"high":0.5,"low":0.47,"amount":139618.20429618,"amplitude":0.062241,"askPrice":0.4832,"askSize":500,"bidPrice":0.4705,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-0.416535,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1770930000000},"marketStatusCode":2,"adr":0,"listingDate":1679025600000,"exchange":"NASDAQ","adjPreClose":0.482,"preHourTrading":{"tag":"盘前","latestPrice":0.4879,"preClose":0.482,"latestTime":"09:00 EST","volume":14794,"amount":7257.08530118,"timestamp":1770904800857,"change":0.0059,"changeRate":0.012241,"amplitude":0.076141},"postHourTrading":{"tag":"盘后","latestPrice":0.4902,"preClose":0.482,"latestTime":"19:23 EST","volume":947,"amount":464.5576,"timestamp":1770855796706,"change":0.0082,"changeRate":0.017012,"amplitude":0.014108},"volumeRatio":1.26184},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OSRH\",,,,,undefined,":{"symbol":"OSRH","floatShares":2342900,"roa":"-1.80%","roe":"-8.95%","lyrEps":-0.537939,"volumeRatio":1.26184,"shares":25672788,"dividePrice":0,"high":0.5,"amplitude":0.062241,"preClose":0.482,"low":0.47,"week52Low":0.453,"pbRate":"0.15","psRate":"-134.70","week52High":10,"institutionHeld":0,"latestPrice":0.4749,"eps":-0.416535,"divideRate":0,"volume":289257,"delay":0,"ttmEps":-0.416535,"open":0.485,"prevYearClose":0.5641,"prevWeekClose":0.55,"prevMonthClose":0.584,"prevQuarterClose":0.5641,"fiveDayClose":0.5143,"twentyDayClose":0.7341,"sixtyDayClose":0.5151},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSRH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"OSRH","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"","actualEps":-0.1},{"market":"US","date":"2025-02-18","symbol":"OSRH","reason":null,"defaultRemindTime":1739889000000,"announcedDate":"2025-02-14","type":"delisting","dateTimestamp":1739854800000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSRH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OSRH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1760936400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OSRH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OSRH","date":"2026-02-11","current":-1.157166,"percent":0.577114,"low":-11.27412,"twenty":-2.795716,"median":-2.181174,"eighty":-1.652392,"high":-0.96142,"avg":-2.968248,"sd":2.586513,"marketCap":13221485},"quantilePoints":[{"date":"2025-04-25","current":-11.034245,"twenty":-11.018253,"median":-10.994266,"eighty":-10.970278,"marketCap":26602229},{"date":"2025-05-02","current":-10.79437,"twenty":-11.034245,"median":-10.954286,"eighty":-10.826353,"marketCap":26023920},{"date":"2025-05-09","current":-10.234662,"twenty":-11.034245,"median":-10.954286,"eighty":-10.60247,"marketCap":24674531},{"date":"2025-05-16","current":-9.115246,"twenty":-11.018253,"median":-10.79437,"eighty":-9.994787,"marketCap":21975754},{"date":"2025-05-23","current":-9.674954,"twenty":-10.954286,"median":-10.194683,"eighty":-9.355121,"marketCap":23325143},{"date":"2025-05-30","current":-2.250878,"twenty":-10.954286,"median":-9.994787,"eighty":-9.115246,"marketCap":23517913},{"date":"2025-06-06","current":-2.582975,"twenty":-10.954286,"median":-9.674954,"eighty":-2.509176,"marketCap":26987769},{"date":"2025-06-13","current":-3.007321,"twenty":-10.79437,"median":-9.275163,"eighty":-2.509176,"marketCap":31421474},{"date":"2025-06-20","current":-2.988871,"twenty":-10.79437,"median":-9.153626,"eighty":-2.568215,"marketCap":31228704},{"date":"2025-06-27","current":-2.306228,"twenty":-10.60247,"median":-3.08112,"eighty":-2.416927,"marketCap":24096222},{"date":"2025-07-03","current":-2.490726,"twenty":-10.362595,"median":-2.988871,"eighty":-2.461206,"marketCap":26023920},{"date":"2025-07-11","current":-2.232429,"twenty":-10.186687,"median":-2.841273,"eighty":-2.416927,"marketCap":23325143},{"date":"2025-07-18","current":-1.844982,"twenty":-10.058754,"median":-2.785923,"eighty":-2.306228,"marketCap":19276978},{"date":"2025-07-25","current":-1.771183,"twenty":-9.994787,"median":-2.638324,"eighty":-2.210289,"marketCap":18505898},{"date":"2025-08-01","current":-1.269717,"twenty":-9.802887,"median":-2.546075,"eighty":-2.07007,"marketCap":13266416},{"date":"2025-08-08","current":-1.142044,"twenty":-9.674954,"median":-2.499951,"eighty":-1.948301,"marketCap":11932449},{"date":"2025-08-15","current":-0.96142,"twenty":-9.483054,"median":-2.490726,"eighty":-1.830222,"marketCap":10045233},{"date":"2025-08-22","current":-1.299897,"twenty":-9.355121,"median":-2.435376,"eighty":-1.667864,"marketCap":10190448},{"date":"2025-08-29","current":-2.038093,"twenty":-9.259171,"median":-2.426603,"eighty":-1.667864,"marketCap":15977483},{"date":"2025-09-05","current":-1.632237,"twenty":-9.193924,"median":-2.416927,"eighty":-1.640717,"marketCap":12795801},{"date":"2025-09-12","current":-1.679596,"twenty":-9.161301,"median":-2.333902,"eighty":-1.610441,"marketCap":13167069},{"date":"2025-09-19","current":-1.986054,"twenty":-9.083263,"median":-2.287778,"eighty":-1.632788,"marketCap":15569520},{"date":"2025-09-26","current":-1.652337,"twenty":-6.653621,"median":-2.204754,"eighty":-1.641103,"marketCap":12953374},{"date":"2025-10-03","current":-1.576755,"twenty":-3.0516,"median":-2.138043,"eighty":-1.5883,"marketCap":12360856},{"date":"2025-10-10","current":-1.679045,"twenty":-2.999941,"median":-2.083765,"eighty":-1.596564,"marketCap":13162752},{"date":"2025-10-17","current":-1.541924,"twenty":-2.981491,"median":-2.038093,"eighty":-1.572212,"marketCap":12087801},{"date":"2025-10-24","current":-1.778444,"twenty":-2.918762,"median":-2.010008,"eighty":-1.579343,"marketCap":13941984},{"date":"2025-10-31","current":-1.802675,"twenty":-2.841273,"median":-1.992581,"eighty":-1.583556,"marketCap":14131935},{"date":"2025-11-07","current":-1.858569,"twenty":-2.833893,"median":-1.970867,"eighty":-1.588796,"marketCap":14570118},{"date":"2025-11-14","current":-1.555691,"twenty":-2.808063,"median":-1.945027,"eighty":-1.583556,"marketCap":12195728},{"date":"2025-11-21","current":-1.77121,"twenty":-2.783942,"median":-1.928782,"eighty":-1.58426,"marketCap":11706791},{"date":"2025-11-28","current":-2.889481,"twenty":-2.815443,"median":-1.941129,"eighty":-1.585735,"marketCap":19097986},{"date":"2025-12-05","current":-2.693716,"twenty":-2.815443,"median":-1.955681,"eighty":-1.59149,"marketCap":17804078},{"date":"2025-12-12","current":-2.526305,"twenty":-2.819064,"median":-1.991658,"eighty":-1.596238,"marketCap":16697581},{"date":"2025-12-19","current":-2.224889,"twenty":-2.800407,"median":-2.025978,"eighty":-1.602941,"marketCap":14705372},{"date":"2025-12-26","current":-2.261012,"twenty":-2.785923,"median":-2.038093,"eighty":-1.624527,"marketCap":14944129},{"date":"2026-01-02","current":-2.191096,"twenty":-2.781961,"median":-2.048832,"eighty":-1.629373,"marketCap":14482019},{"date":"2026-01-09","current":-2.415993,"twenty":-2.76741,"median":-2.094055,"eighty":-1.631907,"marketCap":15968474},{"date":"2026-01-16","current":-3.036693,"twenty":-2.789544,"median":-2.138043,"eighty":-1.633339,"marketCap":20070985},{"date":"2026-01-23","current":-2.975711,"twenty":-2.811546,"median":-2.150311,"eighty":-1.635149,"marketCap":19667922},{"date":"2026-01-30","current":-2.50533,"twenty":-2.811546,"median":-2.188182,"eighty":-1.645541,"marketCap":16558948},{"date":"2026-02-06","current":-1.997661,"twenty":-2.7996,"median":-2.191096,"eighty":-1.652117,"marketCap":13203514},{"date":"2026-02-11","current":-2.00038,"twenty":-2.795716,"median":-2.181174,"eighty":-1.652392,"marketCap":13221485}],"updateTime":1770903070431},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSRH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608086007","title":"OSR Holdings CEO says fundamentals of business ‘remain strong’","url":"https://stock-news.laohu8.com/highlight/detail?id=2608086007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608086007?lang=en_us&edition=fundamental","pubTime":"2026-02-02 22:55","pubTimestamp":1770044128,"startTime":"0","endTime":"0","summary":"In a letter to shareholders, CEO Kuk Hyoun Hwang said, in part, “As the compliance deadline under the minimum bid requirement of NASDAQ approaches,...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/osr-holdings-ceo-says-fundamentals-of-business-remain-strong-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/osr-holdings-ceo-says-fundamentals-of-business-remain-strong-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GPIQ","USAW.SI","NQmain","QQQM","QID","QYLG","JEPQ","SQQQ","QLD","QYLD","MNQmain","QQQY","TSYW.SI","TQQQ","PSQ","QQQE","USJW.SI","NVIW.SI",".IXIC","BK4139","QQQJ","OSRH"],"gpt_icon":0},{"id":"2608860901","title":"OSR Holdings Advances Toward VXM01 Licensing Deal With BCM Europe AG","url":"https://stock-news.laohu8.com/highlight/detail?id=2608860901","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608860901?lang=en_us&edition=fundamental","pubTime":"2026-02-02 22:50","pubTimestamp":1770043815,"startTime":"0","endTime":"0","summary":"OSR Holdings Inc. provided an update on progress toward a potential merger involving its medical device platform. The company highlighted that its subsidiary, Woori IO, which develops medical-grade non-invasive continuous glucose monitoring devices, has begun attracting interest from global device distributors and potential partners for international expansion. When merged with RMC’s established operating platform, the combined entity is expected to form a strong foundation for growth, with plans to evaluate a future listing on Korea’s KOSDAQ market.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire  on February 02, 2026, and is solely re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL6fFVKw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSRH","BK4139"],"gpt_icon":0},{"id":"2606738057","title":"OSR Holdings Closes Woori IO Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2606738057","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606738057?lang=en_us&edition=fundamental","pubTime":"2026-01-27 22:52","pubTimestamp":1769525525,"startTime":"0","endTime":"0","summary":"OSR Holdings Inc. has completed its acquisition of Woori IO, making the company a consolidated subsidiary and strengthening OSR Holdings’ position in medical devices and digital health, particularly in noninvasive glucose monitoring and wearable health technologies. In connection with the closing, legacy shareholders of Woori IO have agreed to a three-year equity alignment framework, exchanging their equity interests in OSR Holdings Co., Ltd. into NASDAQ-listed OSR Holdings common stock at a reference price of $10.00 per share. The company is also reviewing a potential combination of its two medical device subsidiaries, Woori IO and RMC, to form an integrated medical technology and distribution company, with the possibility of pursuing a standalone IPO in Korea in the future.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nNDL7dtFDm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSRH"],"gpt_icon":0},{"id":"2606648733","title":"OSR Holdings Subsidiary Acquires Woori IO to Expand Medtech","url":"https://stock-news.laohu8.com/highlight/detail?id=2606648733","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606648733?lang=en_us&edition=fundamental","pubTime":"2026-01-27 22:47","pubTimestamp":1769525268,"startTime":"0","endTime":"0","summary":"The latest announcement is out from OSR Holdings ( ($OSRH) ). On January 26, 2026, OSR Holdings’ Korean subsidiary, OSR Holdings Co., Ltd. (OSRK), ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/osr-holdings-subsidiary-acquires-woori-io-to-expand-medtech?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/osr-holdings-subsidiary-acquires-woori-io-to-expand-medtech?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSRH","BK4139"],"gpt_icon":0},{"id":"2606780071","title":"Osr Holdings Inc: Evaluating Whether a Combined Platform Could Support a Standalone IPO in Korea","url":"https://stock-news.laohu8.com/highlight/detail?id=2606780071","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606780071?lang=en_us&edition=fundamental","pubTime":"2026-01-27 22:30","pubTimestamp":1769524248,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nFWN3YS0NU:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSRH","BK4139"],"gpt_icon":0},{"id":"2606018780","title":"Osr Holdings Inc: Reviews Strategic Combination of Medical Device Subsidiaries","url":"https://stock-news.laohu8.com/highlight/detail?id=2606018780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606018780?lang=en_us&edition=fundamental","pubTime":"2026-01-27 22:30","pubTimestamp":1769524248,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nFWN3YS0NU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OSRH"],"gpt_icon":0},{"id":"2605949053","title":"Woori IO Accelerates Launch of Noninvasive Glucose Wearables Under OSR Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2605949053","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605949053?lang=en_us&edition=fundamental","pubTime":"2026-01-22 22:56","pubTimestamp":1769093761,"startTime":"0","endTime":"0","summary":"OSR Holdings Subsidiary Woori IO Accelerates Commercialization Following FDA Clarification on Non-Medical Wearables. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. published the original content used to generate this news brief via PR Newswire  on January 22, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL4CZ0Mj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSRH"],"gpt_icon":1},{"id":"2603910389","title":"Vaximm Appoints Sébastien Wieckowski as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2603910389","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603910389?lang=en_us&edition=fundamental","pubTime":"2026-01-16 22:21","pubTimestamp":1768573266,"startTime":"0","endTime":"0","summary":"Vaximm AG, an OSR Holdings Subsidiary, Appoints Sébastien Wieckowski as Chief Scientific Officer to Advance Oral Immunotherapy Platform. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. published the original content used to generate this news brief via PR Newswire  on January 16, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nNDL6hrGSZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSRH","BK4139"],"gpt_icon":0},{"id":"2603009612","title":"OSR Holdings Subsidiary Signs Binding VXM01 Licensing Term Sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2603009612","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603009612?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:48","pubTimestamp":1768402125,"startTime":"0","endTime":"0","summary":"OSR Holdings ( ($OSRH) ) has shared an announcement. On January 13, 2025, Vaximm AG, a wholly owned subsidiary of OSR Holdings, entered into a bind...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/osr-holdings-subsidiary-signs-binding-vxm01-licensing-term-sheet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/osr-holdings-subsidiary-signs-binding-vxm01-licensing-term-sheet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OSRH"],"gpt_icon":0},{"id":"2603614781","title":"BRIEF-Osr Holdings Inc - Vaximm AG Enters Binding Term Sheet With Bcm Europe AG - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603614781","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603614781?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:28","pubTimestamp":1768400919,"startTime":"0","endTime":"0","summary":"BRIEF-Osr Holdings Inc - Vaximm AG Enters Binding Term Sheet With Bcm Europe AG - SEC FilingJan 14  - OSR Holdings Inc OSRH.O:OSR HOLDINGS INC - VAXIMM AG ENTERS BINDING TERM SHEET WITH BCM EUROPE AG - SEC FILINGOSR HOLDINGS INC - BCME TO PAY VAXIMM $30 MILLION UPFRONT AND $815 MILLION IN MILESTONES - SEC FILINGFurther company coverage: OSRH.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF20K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSRH"],"gpt_icon":0},{"id":"2603761420","title":"Osr Holdings Inc - Bcme to Pay Vaximm $30 Mln Upfront and $815 Mln in Milestones - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2603761420","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603761420?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:28","pubTimestamp":1768400884,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nFWN3YF20K:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OSRH"],"gpt_icon":0},{"id":"2603780614","title":"Vaximm Secures $30M Upfront Licensing Deal for VXM01 Through BCM Europe-Managed Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2603780614","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603780614?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:27","pubTimestamp":1768400852,"startTime":"0","endTime":"0","summary":"Vaximm, an OSR Holdings Subsidiary, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 14, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nNDLfwtCq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSRH","BK4139"],"gpt_icon":0},{"id":"2602510930","title":"Vaximm, an Osr Company, Receives Binding Term Sheet From Bcm Europe for Global Exclusive License of Vxm01 With $30M Upfront and up to $815M in Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510930","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510930?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:07","pubTimestamp":1768223229,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD0SY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSRH","BK4139"],"gpt_icon":0},{"id":"2602510963","title":"OSR Holdings Receives Binding Term Sheet for Global VXM01 License Worth Up to $845 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510963","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510963?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223127,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. published the original content used to generate this news brief via PR Newswire  on January 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDLb1F8Ny:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSRH","BK4139"],"gpt_icon":0},{"id":"2592219402","title":"BRIEF-OSR Holdings Says Woori IO Shareholders Approve Share Exchange To Become Unit Of Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2592219402","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592219402?lang=en_us&edition=fundamental","pubTime":"2025-12-20 03:59","pubTimestamp":1766174376,"startTime":"0","endTime":"0","summary":"BRIEF-OSR Holdings Says Woori IO Shareholders Approve Share Exchange To Become Unit Of CoDec 19 (Reuters) - OSR Holdings Inc OSRH.O:WOORI IO SHAREHOLDERS APPROVE SHARE EXCHANGE TO BECOME WHOLLY-OWNED SUBSIDIARY OF OSR HOLDINGS ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nTUABNVF75:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSRH"],"gpt_icon":0},{"id":"2592196716","title":"Woori IO Shareholders Approve Share Exchange with OSR Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2592196716","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592196716?lang=en_us&edition=fundamental","pubTime":"2025-12-20 00:50","pubTimestamp":1766163039,"startTime":"0","endTime":"0","summary":"Woori IO Co., Ltd., a Korean medical device innovator specializing in noninvasive glucose monitoring technology, will become a wholly-owned subsidiary of OSR Holdings Co., Ltd. following shareholder approval of a share exchange at an extraordinary general meeting. According to OSR Holdings Inc., the integration is designed to strengthen Woori IO’s global expansion efforts. Woori IO is currently working with Samsung Electronics on a proof-of-concept study in South Korea and is preparing to launch U.S. clinical initiatives in collaboration with a leading California research university, aiming to advance regulatory and commercial strategies for its breakthrough technology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nNDLbX1zc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSRH","BK4139"],"gpt_icon":0},{"id":"2592196711","title":"Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of Osr Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2592196711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592196711?lang=en_us&edition=fundamental","pubTime":"2025-12-20 00:50","pubTimestamp":1766163025,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251219:nTUABNVF75:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSRH","BK4139"],"gpt_icon":0},{"id":"2589783230","title":"Emerging Growth Research Reaffirms Buy on OSR Holdings With $10 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2589783230","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589783230?lang=en_us&edition=fundamental","pubTime":"2025-12-05 04:19","pubTimestamp":1764879594,"startTime":"0","endTime":"0","summary":"Emerging Growth Research has released a flash report on OSR Holdings Inc. , reaffirming its Buy-Emerging rating and setting a 12-month price target of $10.00, representing a potential 1,487% upside from the company's recent closing price. The report highlights a significant non-binding licensing term sheet between OSR Holdings and BCM Europe AG, valued at $815 million, for the global development and commercialization of OSRH's oral T-cell immunotherapy program, VXM01. The agreement, which includes an expected $20 million upfront payment in 2026 and subsequent milestone payments, is seen as a major validation of OSR Holdings' strategy and management. The research also notes increased likelihood of deal completion and strong cash flow prospects beginning in 2026, positioning OSRH for further potential growth.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gener","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDL4SmJC2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSRH","BK4139"],"gpt_icon":0},{"id":"2588517500","title":"Osr Holdings Inc - Vaximm Ag Shortens Exclusivity Period With Bcm Europe to Three Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2588517500","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588517500?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:55","pubTimestamp":1764687303,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nFWN3X80GK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSRH","BK4139"],"gpt_icon":0},{"id":"2588796051","title":"Vaximm AG Shortens Exclusivity Period With BCM Europe for Cancer Immunotherapy Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2588796051","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588796051?lang=en_us&edition=fundamental","pubTime":"2025-12-02 22:54","pubTimestamp":1764687257,"startTime":"0","endTime":"0","summary":"Vaximm AG, an OSR Holdings Subsidiary, Updates Term Sheet with BCM Europe to Accelerate VXM01 Licensing Deal. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. published the original content used to generate this news brief via PR Newswire  on December 02, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL6vG3kD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSRH","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":50,"code":"91000000","status":"200"}]}}